Tissue-directed antibodies and methods of using the same
US-2024342260-A1 · Oct 17, 2024 · US
against hormones {; against hormone releasing or inhibiting factors}
against hormones {; against hormone releasing or inhibiting factors} · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/26 |
| Official title | against hormones {; against hormone releasing or inhibiting factors} |
| Display label | against hormones {; against hormone releasing or inhibiting factors} |
| Total patents | 601 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 36 |
| 2016 | 47 |
| 2017 | 67 |
| 2018 | 57 |
| 2019 | 82 |
| 2020 | 61 |
| 2021 | 70 |
| 2022 | 52 |
| 2023 | 45 |
| 2024 | 43 |
| 2025 | 34 |
| 2026 | 7 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Bispecific binding molecules binding to VEGF and ANG2
US-9527925-B2 · Dec 27, 2016 · US
Method to detect autoantibody reactivity for deamidated insulin autoantigen in diabetes
US-2016355564-A1 · Dec 8, 2016 · US
Biospecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttles
US-2016324984-A1 · Nov 10, 2016 · US
T cell receptor binding to alwgpdpaaa, derived from human pre-pro insulin (ppi) protein
US-2016318988-A1 · Nov 3, 2016 · US
Insulin assay
US-9476891-B2 · Oct 25, 2016 · US
Antibodies that bind to adrenomedullin and to adrenomedullin receptors and the uses thereof as drugs
US-9474794-B2 · Oct 25, 2016 · US
Identification of a new polypeptide hormone for maintenance of optimal body weight and blood glucose
US-2016289289-A1 · Oct 6, 2016 · US
Compositions and methods for antibodies targeting epo
US-2016280783-A1 · Sep 29, 2016 · US
Uses of modified mullerian inhibiting substance (mis) proteins for the treatment of neurodegenerative diseases
US-2016228514-A1 · Aug 11, 2016 · US
Method for evaluating salivary adiponectin level and kit for measuring salivary adiponectin level
US-2016195551-A1 · Jul 7, 2016 · US
Use of proinsulin for immune system modulation
US-2016184402-A1 · Jun 30, 2016 · US
Compoitions and methods for modulating thermogenesis using pth-related and egf-related compounds
US-2016175401-A1 · Jun 23, 2016 · US
Compositions and methods for antibodies targeting EPO
US-9365646-B2 · Jun 14, 2016 · US
Augurin immunoassay
US-2016146840-A1 · May 26, 2016 · US
Pathway specific markers for diagnosing irritable bowel syndrome
US-2016139148-A1 · May 19, 2016 · US
Antibodies to human resistin
US-2016130341-A1 · May 12, 2016 · US
Tsh antibodies for point-of-care immunoassay formats
US-2016109466-A1 · Apr 21, 2016 · US
Anti-hepcidin antibodies and methods of use
US-9315577-B2 · Apr 19, 2016 · US
Polypeptides, nucleic acids and uses thereof
US-9309314-B2 · Apr 12, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/26?
- CPC C07K16/26 is the Cooperative Patent Classification code for “against hormones {; against hormone releasing or inhibiting factors}.”
- How many patents are filed under CPC C07K16/26 (against hormones {; against hormone releasing or inhibiting factors})?
- Our database includes 601 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/26 growing?
- Publication counts under this code: 43 in 2024 vs 34 in 2025 (latest complete years).